General Announcement::Outcome of Board Meeting and Audited Financial Result For The Year Ended March 31 2018

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
29-May-2018 23:12:59
Status
New
Announcement Sub Title
Outcome of Board Meeting and Audited Financial Result For The Year Ended March 31 2018
Announcement Reference
SG180529OTHRHAAQ
Submitted By (Co./ Ind. Name)
GLENMARK PHARMACEUTICALS LTD
Designation
COMPANY SECRETARY & COMPLIANCE OFFICER
Effective Date and Time of the event
30/05/2018 17:00:00
Description (Please provide a detailed description of the event in the box below)
Attached herewith is the Outcome of the Board Meeting held on May 29, 2018 and Audited Financial Result for the year ended March 31, 2018

Attachments

SGX_Results.pdf
Total size =7856K